
Dr. Mark Demesmaeker
Fähigkeiten und Kenntnisse
Werdegang
Berufserfahrung von Mark Demesmaeker
- Bis heute 2 Jahre und 6 Monate, seit Nov. 2022
Head of Digital Strategy and Product Portfolio
Cytiva (formerly GE Life Sciences)
At Cytiva my role is to create and continuosly evolve Cytiva's portfolio of advanced digital products and services - pushing the boundaries of digital process development and Biomanufacturing of life saving drugs and vacines.
- 4 Jahre und 6 Monate, Juni 2018 - Nov. 2022
Head of Data Analytics
Sartorius Stedim Biotech
- 2 Jahre und 7 Monate, Dez. 2015 - Juni 2018
Vice President, Translational & Clinical Analytics
PerkinElmer Inc.
At PerkinElmer Informatics I am responsible for developing and implementing the global analytics product strategy and services portfolio to drive analytics across healthcare, life and physical sciences markets. My role includes defining the go-to-market strategy, development of external collaborations (including potential partnership and strategic acquisitions), as well as thought leader relationships to manage and effect technology assessment and platform development.
At IBM my role was to lead Life Science Analytics within the central EMEA region, shaping the delivery team and go to-market strategy around eHealth and Real-World Evidence in close cooperation with the IBM Watson Health Unit.
- 1 Jahr und 4 Monate, Jan. 2014 - Apr. 2015
Managing Director, EMEA & Asia Operations
Integrated Clinical Systems Inc.
I am currently managing EMEA & Asia Operations of Integrated Clinical Systems Inc. ICS has developed JReview®, the most comprehensive clinical review and -analysis software tool in the market. It provides an intuitive user interface to perform the tasks required to conduct safety and efficacy review, as well as risk-based monitoring activities through clinically relevant reports and interactive data visualizations.
- 1 Jahr und 5 Monate, Sep. 2012 - Jan. 2014
Director, Industry Analytics
Tibco Software AG
- Practice lead in advanced analytics - injecting subject matter expertise to all phases of the sales and delivery cycle. Define innovative and predictive analytic applications solving business-critical issues in the Life Sciences, Energy, Financial Services, Consumer Goods & Retail (CPR) and Telco, Media & Networks industries. - EU Press- and Analyst spokesperson for TIBCO Spotfire
- 11 Jahre und 5 Monate, Apr. 2001 - Aug. 2012
European Manager, Solutions Consulting
Tibco Software AG
- Manage/grow TIBCO Spotfire’s EMEA solutions consulting organization - covering various markets, such as pharmaceuticals/life sciences, financial services, energy, high-tech manufacturing, and telecommunications. - Manage business analytics consulting engagements with numerous global Pharmaceutical- and Biotech corporations, aimed at optimizing business analytics processes as well as the performance of R&D-, and sales & marketing organizations. - Technical/scientific field marketing - EU Press- and A
- 1 Jahr und 4 Monate, Jan. 2000 - Apr. 2001
Scientific Consultant
Spotfire, Inc.
- Global pre-sales consulting with Spotfire’s strategic life science customers, positioning and designing data analytics workflows across all verticals within pharmaceutical R&D (genomics, proteomics, screening, medicinal chemistry, pre-clinical-, and clinical development (phases I-IV)). - Speaker at multiple international scientific congresses and seminars. - Development of Spotfire product- and market strategies for life science R&D.
- 2 Jahre und 7 Monate, Juni 1997 - Dez. 1999
Technical Officer, Quality Assurance and Safety: Medicines
World Health Organization, Geneva, Switzerland
- International Pharmacopoeia - WHO expert committes on quality of pharmaceutical products - International Nonproprietary Names (INN) for pharmaceuticals - International Conference on Harmonization (ICH)
- 4 Jahre und 8 Monate, Okt. 1992 - Mai 1997
Reasearch Fellow, Post-doc
Pharmazeutisches Institut, Universität Kiel, Germany
- Teaching: Medicinal chemistry & pharmacology; Lab research in drug metabolism & carcinogenesis
Ausbildung von Mark Demesmaeker
- 2007 - 2008
Business & Administration
IMD Business School, Lausanne, Switzerland
- 1992 - 1997
Pharmacokinetics
Christian Albrechts Universität Kiel, Germany
Ph.D. Thesis in Pharmacokinetics/Drug Metabolism & Medicinal Chemistry - Postdoc
- 1988 - 1991
Pharmaceutical Sciences
Rheinische Friedrich-Wilhelms-Universität Bonn, Germany
Sprachen
Deutsch
-
Englisch
-
Spanisch
-
Französisch
-
XING Mitglieder mit ähnlichen Profilangaben
XING – Das Jobs-Netzwerk
Über eine Million Jobs
Entdecke mit XING genau den Job, der wirklich zu Dir passt.
Persönliche Job-Angebote
Lass Dich finden von Arbeitgebern und über 20.000 Recruiter·innen.
22 Mio. Mitglieder
Knüpf neue Kontakte und erhalte Impulse für ein besseres Job-Leben.
Kostenlos profitieren
Schon als Basis-Mitglied kannst Du Deine Job-Suche deutlich optimieren.